CombinedError

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.

Zynex 

NASDAQ

Free

Zynex 's Price growth average in the last 3 years of 31.23% is great compared to market average of 9.66%. This indicates ZYXI could be a good value stock.

Price growth average in the last 3 years vs Market

Zynex 's Owned by institutions of 26.42% is modest compared to market average of 70.07%. This indicates ZYXI could have a small participation of stakeholders.

Owned by institutions vs Market

Value

Quality

Ownership

Growth

Dividends

is a comprehensive guide for investors seeking income investments. It helps discover stocks with attractive dividend yield trends and growth potential based on historical data.

empowers investors by providing accurate growth forecasts and indicators, enabling them to make proactive choices and build winning portfolios.

reveals confidence through institutional and insider holdings, which help investors understand the dynamics of stock ownership.

assesses a company's operational efficiency, financial health, stability, and growth potential, aiding investment decisions.

is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

helps identify undervalued stocks based on fundamentals, ideal for value investors like Warren Buffett.

Performance History

Score Breakdown

Welcome to Stocklytics

Analyst Forecast

Analyst Ratings

Zynex (ZYXI)

Keep an eye on Zynex

Take Your Investments to a Whole New Level